“From Plants to Premium Products”
Rapidly emerging biotechnology company focused on cannabis cultivation and research; based in the Okanagan Valley of B.C.
Positioned to capitalize on Canada’s international lead in regulation, research, development and production, to become a global, vertically integrated medical cannabis company.
Assembling “Best-In-Class” fully licensed cannabis focused companies that are horizontally integrated “From Plants to Premium Products”
To be the most profitable, fully-integrated Plants to Premium Products (“P2P”) cannabis-focused company through the creation of a “Best Practices, R&D-backed, end-to-end Global Bioscience Platform”.
Focused on quality organic product demanding premium pricing with exceptional profit margins
17,000 sf state-of-the-art research Cannabis Cultivation Facility
Customized Derivative Production
Contract R&D Operations
Leading Edge Analytical Services & Research
Research and Development:
Supra is licensed by Health Canada to conduct research, provide chemical analysis and produce extracts and derivatives of cannabis materials in addition to offering analytical services to the wider natural health product sector. Our corporate mandate is to provide scientific leadership and to support the production of the highest quality herbal medicinal products on the market.
Facilities Build Out, Licensing & Production
On May 26, 2017 Health Canada introduced several improvements to its medical cannabis program, expected to have direct application to the Company’s expansion plans.
Potential near-term issuance of an LP to the Company, and expedited acquisition of an LS concurrent to our DL cultivation activities.
Assumptions, based on management estimates and experience:
Also, grow-room expansion and additions to extraction capability is commencing to accommodate initial harvests to meet Dealers Licence-related commercial purchase orders. This will include Food Grade/ISO Certification, vault renovation, ISO 9001 extraction & derivative production.
MKV Ventures 1, LLC (“MKV”), a wholly-owned subsidiary of MKHS, LLC, has engaged VGW to help manage and fund expansion on its 9.5 acre operating site:
Download our latest Corporate Presentation:
We are a publicly traded Canadian company listed on the Canadian Securities Exchange (VGW-C).
We just completed (Nov 2016) an RTO and changed our name from Genovation Capital Corp.
Our old website with historical filings remains accessible at www.genovationcapital.ca pending the rollout of our permanent website.
We love to meet with our shareholders, potential investors and industry participants, so feel free to arrange a visit during normal business hours at our Okanagan Valley facility.